|
| Press Releases |
|
 |
|
| Friday, November 15, 2019 |
|
|
Global BioLife to Present 3F Antimicrobial Fragrance at 2020 ASM Biothreats |
| Global BioLife Inc, the U.S.subsidiary of SGX-listed Singapore eDevelopment Ltd (SeD), will present research on its 3F Antimicrobial Fragrance as a new method to prevent and treat Tuberculosis at the 2020 ASM Biothreats conference, taking place from 28 to 30 January 2020 in Arlington, Virginia. more info >> |
|
| Tuesday, October 29, 2019 |
|
|
Global BioLife to present Functional Fragrance Formula at the American Society for Microbiology's Biothreats Conference as a New Method to Prevent and Treat Tuberculosis |
| SGX-listed Singapore eDevelopment Limited ("SeD", SGX:40V) wishes to announce that its biomedical subsidiary incorporated in Nevada, Global BioLife Inc. ("Global BioLife") will be presenting its research on its Functional Fragrance Formula ("3F") against tuberculosis at the 2020 American Society for Microbiology ("ASM") Biothreats Conference. more info >> |
|
| Wednesday, July 24, 2019 |
|
|
Global BioLife unveils naturally modified Laetose at Harvard Global Catalyst Health Summit |
| SGX-listed Singapore eDevelopment Ltd (SeD) is pleased to announce the results of clinical trials conducted on Laetose(TM), developed by its U.S. biomedical subsidiary, Global BioLife Inc. ("Global BioLife"). more info >> |
|
| Wednesday, June 12, 2019 |
|
|
Global BioLife's 3F Mosquito Repellent Formula performs well in Independent Testing |
| SGX-listed Singapore eDevelopment Ltd (SeD) wishes to announce that its U.S. biomedical subsidiary Global BioLife Inc. has independently tested its new 3F Mosquito Formula which performs well against mosquitoes for six (6) to eight (8) hours. more info >> |
|
| Monday, January 28, 2019 |
|
|
Global BioLife's 3F Antimicrobial Fragrance shows Efficacy against Tuberculosis |
| SGX-listed Singapore eDevelopment Ltd (SeD) is pleased to announce that its U.S. biomedical subsidiary Global BioLife Inc. has developed 3F Antimicrobial Fragrance, which shows efficacy against tuberculosis. more info >> |
|
| Wednesday, November 7, 2018 |
|
|
Singapore eDevelopment's Global BioLife to present Parkinson's Research at Neuroscience 2018 |
| Singapore eDevelopment (SGX: 40V) ("SeD") subsidiary, Global BioLife Inc. is pleased to announce that research of their promising drug platform, Linebacker, will be presented at Neuroscience 2018, the Annual Meeting for the International Society for Neuroscience (SfN) in San Diego, California. more info >> |
|
| Monday, June 18, 2018 |
|
|
Singapore eDevelopment Limited Announces Corporate and Business Update |
| The Board of Directors of Singapore eDevelopment Limited wishes to provide shareholders an update on the Group's operations. more info >> |
|
| Thursday, May 31, 2018 |
|
|
Singapore eDevelopment's Global BioLife develops Low Glycemic Modified Sugar |
| Singapore Exchange-listed Singapore eDevelopment Limited ("SeD") announced today that its U.S. biomedical subsidiary, Global BioLife, Inc. ("Global BioLife"), has developed a low glycemic index, naturally modified sugar - Laetose - which has the potential to affect the world's sugar market. more info >> |
|
| Thursday, March 1, 2018 |
|
|
Singapore eDevelopment's Global BioLife confirms LB2 efficacy against Ebola |
| Singapore eDevelopment (SGX: 40V; SeD) is pleased to announce biomedical subsidiary Global BioLife, Inc. has completed the initial Zaire Ebola research portion for the study of new anti-viral drug LB2, part of its new universal therapeutic drug platform, Linebacker. more info >> |
|
| Wednesday, November 1, 2017 |
|
|
Singapore eDevelopment's Global BioLife confirms 100% Repellency of 3F Mosquito Fragrance |
| SGX-listed Singapore eDevelopment Ltd (SeD) announced today that its U.S. biomedical subsidiary, Global BioLife Inc. has completed development and testing of mosquito deterring technologies including fragrances, paints, and fabric. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
碧瑶绿色集团（股份代号：01397）公布2025年全年业绩 纯利跃升72%至9,700万港元 创上市新高
Mar 24, 2026 19:53 HKT/SGT
|
|
|
国泰君安国际保荐凯乐士科技 助力综合智能场内物流机器人龙头扬帆远航
Mar 24, 2026 19:40 HKT/SGT
|
|
|
國泰君安國際保薦凱樂士科技 助力綜合智能場內物流機器人龍頭揚帆遠航
Mar 24, 2026 19:32 HKT/SGT
|
|
|
USPA Global 與 ESPN 擴大合作關係，攜手克里斯·福勒（Chris Fowler）共同呈現 2026 年高分級馬球錦標賽
Mar 24, 2026 19:00 HKT/SGT
|
|
|
USPA Global 与 ESPN 深化合作，携手克里斯·福勒共同呈现 2026 年高目标马球锦标赛
Mar 24, 2026 19:00 HKT/SGT
|
|
|
USPA Global and ESPN Expand Relationship with Chris Fowler for 2026 High-Goal Polo Championships
Mar 24, 2026 19:00 HKT/SGT
|
|
|
中國抗體（03681.HK）2025年度虧損同比下降約43.3% 管線開發取得重大進展
Mar 24, 2026 18:11 HKT/SGT
|
|
|
SinoMab (03681.HK) Achieves Approximately 43.3% Year-over-Year Decrease in Annual Losses for 2025, Marking Significant Progress in Pipeline Advancement
Mar 24, 2026 17:53 HKT/SGT
|
|
|
中国抗体（03681.HK）2025年度亏损同比下降约43.3% 管线开发取得重大进展
Mar 24, 2026 17:44 HKT/SGT
|
|
|
HIES introduces plant-based lubricant that reduces air compressor lifecycle CO(2) emissions by 40%
Mar 24, 2026 18:07 JST
|
|
|
同仁堂醫養（02667.HK）基石鎖定逾46% "百年中醫第一股"認購進入最後倒計時
Mar 24, 2026 15:25 HKT/SGT
|
|
|
同仁堂医养（02667.HK）基石锁定逾46% "百年中医第一股"认购进入最后倒计时
Mar 24, 2026 15:25 HKT/SGT
|
|
|
OMP Positioned Highest for Both Completeness of Vision and Ability to Execute in the 2026 Gartner(R) Magic Quadrant(TM) for Supply Chain Planning Solutions: Process Industries
Mar 24, 2026 15:11 HKT/SGT
|
|
|
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Mar 24, 2026 15:03 HKT/SGT
|
|
|
三菱造船、水産研究・教育機構向け漁業調査船「蒼鷹丸」の命名・進水式を下関で実施
Mar 24, 2026 15:00: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
